A citation-based method for searching scientific literature

Jeppe Sejerø Holm, Samuel A Funt, Annie Borch, Kamilla Kjærgaard Munk, Anne-Mette Bjerregaard, James L Reading, Colleen Maher, Ashley Regazzi, Phillip Wong, Hikmat Al-Ahmadie, Gopa Iyer, Tripti Tamhane, Amalie Kai Bentzen, Nana Overgaard Herschend, Susan De Wolf, Alexandra Snyder, Taha Merghoub, Jedd D Wolchok, Morten Nielsen, Jonathan E Rosenberg, Dean F Bajorin, Sine Reker Hadrup. Nat Commun 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy.
Afsheen Raza, Maysaloun Merhi, Varghese Philipose Inchakalody, Roopesh Krishnankutty, Allan Relecom, Shahab Uddin, Said Dermime. J Transl Med 2020
31
100

Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma.
Zhuting Hu, Donna E Leet, Rosa L Allesøe, Giacomo Oliveira, Shuqiang Li, Adrienne M Luoma, Jinyan Liu, Juliet Forman, Teddy Huang, J Bryan Iorgulescu,[...]. Nat Med 2021
82
100

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab.
Alexander Martens, Kilian Wistuba-Hamprecht, Marnix Geukes Foppen, Jianda Yuan, Michael A Postow, Phillip Wong, Emanuela Romano, Amir Khammari, Brigitte Dreno, Mariaelena Capone,[...]. Clin Cancer Res 2016
358
100

Cancer immunotherapy: it's time to better predict patients' response.
Charlotte Pilard, Marie Ancion, Philippe Delvenne, Guy Jerusalem, Pascale Hubert, Michael Herfs. Br J Cancer 2021
9
100

Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.
Nicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, Sofie Ramskov, Rikke Lyngaa, Sunil Kumar Saini, Mariam Jamal-Hanjani, Gareth A Wilson, Nicolai J Birkbak, Crispin T Hiley,[...]. Science 2016
100

Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma.
Henning Zelba, Benjamin Weide, Alexander Martens, Evelyna Derhovanessian, Jithendra Kini Bailur, Christina Kyzirakos, Annette Pflugfelder, Thomas K Eigentler, Anna Maria Di Giacomo, Michele Maio,[...]. Clin Cancer Res 2014
32
100

Monitoring of technical variation in quantitative high-throughput datasets.
Martin Lauss, Ilhami Visne, Albert Kriegner, Markus Ringnér, Göran Jönsson, Mattias Höglund. Cancer Inform 2013
44
100

Complex heatmaps reveal patterns and correlations in multidimensional genomic data.
Zuguang Gu, Roland Eils, Matthias Schlesner. Bioinformatics 2016
100

The role of neoantigen in immune checkpoint blockade therapy.
Ming Yi, Shuang Qin, Weiheng Zhao, Shengnan Yu, Qian Chu, Kongming Wu. Exp Hematol Oncol 2018
67
100

Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
Alice O Kamphorst, Rathi N Pillai, Shu Yang, Tahseen H Nasti, Rama S Akondy, Andreas Wieland, Gabriel L Sica, Ke Yu, Lydia Koenig, Nikita T Patel,[...]. Proc Natl Acad Sci U S A 2017
383
100


Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients.
Alena Gros, Maria R Parkhurst, Eric Tran, Anna Pasetto, Paul F Robbins, Sadia Ilyas, Todd D Prickett, Jared J Gartner, Jessica S Crystal, Ilana M Roberts,[...]. Nat Med 2016
511
100

Signatures of mutational processes in human cancer.
Ludmil B Alexandrov, Serena Nik-Zainal, David C Wedge, Samuel A J R Aparicio, Sam Behjati, Andrew V Biankin, Graham R Bignell, Niccolò Bolli, Ake Borg, Anne-Lise Børresen-Dale,[...]. Nature 2013
100

Early disappearance of tumor antigen-reactive T cells from peripheral blood correlates with superior clinical outcomes in melanoma under anti-PD-1 therapy.
Jonas Bochem, Henning Zelba, Janine Spreuer, Teresa Amaral, Nikolaus B Wagner, Andrea Gaissler, Oltin T Pop, Karolin Thiel, Can Yurttas, Daniel Soffel,[...]. J Immunother Cancer 2021
1
100

The Human Vaccines Project: A roadmap for cancer vaccine development.
Pedro Romero, Jacques Banchereau, Nina Bhardwaj, Mark Cockett, Mary L Disis, Glenn Dranoff, Eli Gilboa, Scott A Hammond, Robert Hershberg, Alan J Korman,[...]. Sci Transl Med 2016
104
100

Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy.
Sara Valpione, Elena Galvani, Joshua Tweedy, Piyushkumar A Mundra, Antonia Banyard, Philippa Middlehurst, Jeff Barry, Sarah Mills, Zena Salih, John Weightman,[...]. Nat Cancer 2020
69
100

Regularization Paths for Generalized Linear Models via Coordinate Descent.
Jerome Friedman, Trevor Hastie, Rob Tibshirani. J Stat Softw 2010
100

Melan-A/MART-1-specific CD8 T cells: from thymus to tumor.
Mikaël J Pittet, Alfred Zippelius, Danila Valmori, Daniel E Speiser, Jean-Charles Cerottini, Pedro Romero. Trends Immunol 2002
44
100

LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade.
Ronglai Shen, Michael A Postow, Matthew Adamow, Arshi Arora, Margaret Hannum, Colleen Maher, Phillip Wong, Michael A Curran, Travis J Hollmann, Liwei Jia,[...]. Sci Transl Med 2021
16
100

Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis.
Benjamin Weide, Henning Zelba, Evelyna Derhovanessian, Annette Pflugfelder, Thomas K Eigentler, Anna Maria Di Giacomo, Michele Maio, Erik H J G Aarntzen, I Jolanda M de Vries, Antje Sucker,[...]. J Clin Oncol 2012
92
100

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
100


Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells.
Benjamin Weide, Alexander Martens, Henning Zelba, Christina Stutz, Evelyna Derhovanessian, Anna Maria Di Giacomo, Michele Maio, Antje Sucker, Bastian Schilling, Dirk Schadendorf,[...]. Clin Cancer Res 2014
179
100

TIM3 comes of age as an inhibitory receptor.
Yochai Wolf, Ana C Anderson, Vijay K Kuchroo. Nat Rev Immunol 2020
240
100

Regulatory T cells in cancer immunotherapy.
Atsushi Tanaka, Shimon Sakaguchi. Cell Res 2017
691
100

PD-1 and LAG-3 Dominate Checkpoint Receptor-Mediated T-cell Inhibition in Renal Cell Carcinoma.
Henning Zelba, Jens Bedke, Jörg Hennenlotter, Sven Mostböck, Markus Zettl, Thomas Zichner, Anoop Chandran, Arnulf Stenzl, Hans-Georg Rammensee, Cécile Gouttefangeas. Cancer Immunol Res 2019
31
100

Cancer immunotherapy using checkpoint blockade.
Antoni Ribas, Jedd D Wolchok. Science 2018
100

The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies.
Shogo Kumagai, Yosuke Togashi, Takahiro Kamada, Eri Sugiyama, Hitomi Nishinakamura, Yoshiko Takeuchi, Kochin Vitaly, Kota Itahashi, Yuka Maeda, Shigeyuki Matsui,[...]. Nat Immunol 2020
160
100

A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanoma.
Alexander C Huang, Robert J Orlowski, Xiaowei Xu, Rosemarie Mick, Sangeeth M George, Patrick K Yan, Sasikanth Manne, Adam A Kraya, Bradley Wubbenhorst, Liza Dorfman,[...]. Nat Med 2019
275
100

T Cell Dysfunction in Cancer.
Daniela S Thommen, Ton N Schumacher. Cancer Cell 2018
441
100

Improved survival with ipilimumab in patients with metastatic melanoma.
F Stephen Hodi, Steven J O'Day, David F McDermott, Robert W Weber, Jeffrey A Sosman, John B Haanen, Rene Gonzalez, Caroline Robert, Dirk Schadendorf, Jessica C Hassel,[...]. N Engl J Med 2010
100

Dissection of T-cell antigen specificity in human melanoma.
Rikke Sick Andersen, Charlotte Albæk Thrue, Niels Junker, Rikke Lyngaa, Marco Donia, Eva Ellebæk, Inge Marie Svane, Ton N Schumacher, Per Thor Straten, Sine Reker Hadrup. Cancer Res 2012
113
100

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types.
Vinicius Araujo B de Lima, Morten Hansen, Iben Spanggaard, Kristoffer Rohrberg, Sine Reker Hadrup, Ulrik Lassen, Inge Marie Svane. Front Oncol 2021
6
100

Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.
Jedd D Wolchok, Vanna Chiarion-Sileni, Rene Gonzalez, Piotr Rutkowski, Jean-Jacques Grob, C Lance Cowey, Christopher D Lao, John Wagstaff, Dirk Schadendorf, Pier F Ferrucci,[...]. N Engl J Med 2017
100

Large-scale detection of antigen-specific T cells using peptide-MHC-I multimers labeled with DNA barcodes.
Amalie Kai Bentzen, Andrea Marion Marquard, Rikke Lyngaa, Sunil Kumar Saini, Sofie Ramskov, Marco Donia, Lina Such, Andrew J S Furness, Nicholas McGranahan, Rachel Rosenthal,[...]. Nat Biotechnol 2016
164
100

Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.
Anastasia Gangaev, Elisa A Rozeman, Maartje W Rohaan, Olga I Isaeva, Daisy Philips, Sanne Patiwael, Joost H van den Berg, Antoni Ribas, Dirk Schadendorf, Bastian Schilling,[...]. Proc Natl Acad Sci U S A 2021
3
100

Luminex-Based Methods in High-Resolution HLA Typing.
Manuela Testi, Marco Andreani. Methods Mol Biol 2015
12
100

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.
Carsten Krieg, Malgorzata Nowicka, Silvia Guglietta, Sabrina Schindler, Felix J Hartmann, Lukas M Weber, Reinhard Dummer, Mark D Robinson, Mitchell P Levesque, Burkhard Becher. Nat Med 2018
364
100

Cancer vaccines: shared tumor antigens return to the spotlight.
Lijin Li, S Peter Goedegebuure, William Gillanders. Signal Transduct Target Ther 2020
9
100

Cancer Neoantigens.
Ton N Schumacher, Wouter Scheper, Pia Kvistborg. Annu Rev Immunol 2019
217
100

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
Remy Thomas, Ghaneya Al-Khadairi, Jessica Roelands, Wouter Hendrickx, Said Dermime, Davide Bedognetti, Julie Decock. Front Immunol 2018
151
100

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints.
Shohei Koyama, Esra A Akbay, Yvonne Y Li, Grit S Herter-Sprie, Kevin A Buczkowski, William G Richards, Leena Gandhi, Amanda J Redig, Scott J Rodig, Hajime Asahina,[...]. Nat Commun 2016
828
100

T-cell invigoration to tumour burden ratio associated with anti-PD-1 response.
Alexander C Huang, Michael A Postow, Robert J Orlowski, Rosemarie Mick, Bertram Bengsch, Sasikanth Manne, Wei Xu, Shannon Harmon, Josephine R Giles, Brandon Wenz,[...]. Nature 2017
835
100

Treatment of Advanced Melanoma in 2020 and Beyond.
Russell W Jenkins, David E Fisher. J Invest Dermatol 2021
74
100

circlize Implements and enhances circular visualization in R.
Zuguang Gu, Lei Gu, Roland Eils, Matthias Schlesner, Benedikt Brors. Bioinformatics 2014
100

Tumor Mutational Burden and Response Rate to PD-1 Inhibition.
Mark Yarchoan, Alexander Hopkins, Elizabeth M Jaffee. N Engl J Med 2017
100

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.
Martin Sebastian, Andreas Schröder, Birgit Scheel, Henoch S Hong, Anke Muth, Lotta von Boehmer, Alfred Zippelius, Frank Mayer, Martin Reck, Djordje Atanackovic,[...]. Cancer Immunol Immunother 2019
55
100



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.